A research team has discovered a previously overlooked subtype of brain tumor termed IME IDH-mutant astrocytoma. Contrary to typical medical expectations, this subtype exhibits strong immune activity, classified as “immune‑hot,” yet tends to have poorer survival rates, and may respond differently to treatments compared to other types. In addition, the team has developed an AI framework to assist doctors in accurately identifying this subtype, enabling more personalized patient care.
This article was originally published on MedicalXpress.com
